Qingdao Vland Biotech INC., a prominent player in the biotechnology sector, is headquartered in Qingdao, China. Established in 2003, the company has made significant strides in the development and production of high-quality enzymes and probiotics, catering to various industries including food, agriculture, and pharmaceuticals. Vland Biotech is renowned for its innovative approach to enzyme production, utilising advanced fermentation technology to create unique products that enhance food safety and nutritional value. With a strong market presence in Asia and expanding operations globally, the company has achieved notable milestones, including numerous industry awards for its commitment to quality and sustainability. As a leader in the biotech field, Qingdao Vland Biotech INC. continues to set benchmarks for excellence, driving advancements that benefit both consumers and the environment.
How does Qingdao Vland Biotech INC.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Qingdao Vland Biotech INC.'s score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Qingdao Vland Biotech INC., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to mitigate its carbon footprint at this time. As there are no emissions data or reduction initiatives available, it is unclear how Qingdao Vland Biotech INC. aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the biotech sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets in line with global climate goals. In summary, Qingdao Vland Biotech INC. currently lacks specific emissions data and formal climate commitments, highlighting an area for potential improvement in transparency and sustainability practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Qingdao Vland Biotech INC. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

